Drugs that contain Epinephrine

1. Drug name - ADRENACLICK

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7297136 IMPAX Medicine injection devices and methods
Jan, 2025

(2 years from now)

US10166334 IMPAX Medicine injection apparatuses
Jan, 2025

(2 years from now)

US7621891 IMPAX Method and apparatus for delivering epinephrine
Feb, 2025

(2 years from now)

US7905352 IMPAX Kits containing medicine injection devices and containers
Apr, 2027

(4 years from now)

Market Authorisation Date: 30 May, 2003

Treatment: NA

Dosage: INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS

More Information on Dosage
Strength Dosage Availability
EQ 0.15MG/DELIVERY INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS Discontinued
EQ 0.3MG/DELIVERY INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS Discontinued

2. Drug name - ADRENALIN

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9295657 PAR STERILE PRODUCTS Epinephrine formulations
Mar, 2035

(12 years from now)

US9119876 PAR STERILE PRODUCTS Epinephrine formulations
Mar, 2035

(12 years from now)

US10130592 PAR STERILE PRODUCTS Epinephrine formulations
Mar, 2035

(12 years from now)

Market Authorisation Date: 07 December, 2012

Treatment: Emergency treatment of allergic reactions (type i), including anaphylaxis

Dosage: SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS

More Information on Dosage
Strength Dosage Availability
EQ 1MG BASE/ML (EQ 1MG BASE/ML) SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS Prescription

3. Drug name - AUVI-Q

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8313466 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(1 year, 11 months from now)

US10314977 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(1 year, 11 months from now)

US9737669 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(1 year, 11 months from now)

US8920377 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(1 year, 11 months from now)

US8361029 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(1 year, 11 months from now)

US9056170 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(1 year, 11 months from now)

US8608698 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(1 year, 11 months from now)

US7918823 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(1 year, 11 months from now)

US10737028 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(1 year, 11 months from now)

US8425462 KALEO INC Devices, systems, and methods for medicament delivery
Nov, 2024

(1 year, 11 months from now)

US9833573 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(1 year, 11 months from now)

US7731690 KALEO INC Devices, systems and methods for medicament delivery
Jan, 2025

(2 years from now)

US8016788 KALEO INC Devices, systems and methods for medicament delivery
Mar, 2025

(2 years from now)

US10335549 KALEO INC Devices, systems and methods for medicament delivery
Apr, 2025

(2 years from now)

US9149579 KALEO INC Devices, systems and methods for medicament delivery
Jul, 2025

(2 years from now)

US9259539 KALEO INC Devices, systems and methods for medicament delivery
Feb, 2026

(3 years from now)

US9278182 KALEO INC Devices, systems and methods for medicament delivery
Feb, 2026

(3 years from now)

US8926594 KALEO INC Devices, systems and methods for medicament delivery
Mar, 2026

(3 years from now)

US7731686 KALEO INC Devices, systems and methods for medicament delivery
Jun, 2026

(3 years from now)

US10960155 KALEO INC Devices, systems and methods for medicament delivery
Jun, 2026

(3 years from now)

US9238108 KALEO INC Medicament delivery device having an electronic circuit system
Feb, 2027

(4 years from now)

US8206360 KALEO INC Devices, systems and methods for medicament delivery
Feb, 2027

(4 years from now)

US9724471 KALEO INC Devices, systems, and methods for medicament delivery
May, 2027

(4 years from now)

US7947017 KALEO INC Devices, systems and methods for medicament delivery
Mar, 2028

(5 years from now)

US7749194 KALEO INC Devices, systems, and methods for medicament delivery
Oct, 2028

(5 years from now)

US8231573 KALEO INC Medicament delivery device having an electronic circuit system
Nov, 2028

(5 years from now)

US8226610 KALEO INC Medical injector with compliance tracking and monitoring
Apr, 2029

(6 years from now)

US8021344 KALEO INC Medicament delivery device configured to produce an audible output
Nov, 2029

(6 years from now)

US10688244 KALEO INC Medicament delivery device and methods for delivering drugs to infants and children
Dec, 2037

(15 years from now)

US10842938 KALEO INC Medicament delivery device and methods for delivering drugs to infants and children
Dec, 2037

(15 years from now)

Market Authorisation Date: 10 August, 2012

Treatment: Method to treat severe allergic emergencies in patients weighing 7.5 to 15 kg (16.5 to 33 lbs); Method of treating allergic reaction via injection; Method for confirming dose delivery; Method of treating an allergic reaction using an auto-injector

Dosage: SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS

More Information on Dosage
Strength Dosage Availability
EQ 0.1MG/DELIVERY SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS Prescription
EQ 0.15MG/DELIVERY SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS Prescription
EQ 0.3MG/DELIVERY SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS Prescription

4. Drug name - EPI E Z PEN JR

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8870827 MYLAN SPECIALITY LP Automatic injector
Sep, 2025

(2 years from now)

US9586010 MYLAN SPECIALITY LP Automatic injector with needle cover
Sep, 2025

(2 years from now)

US7794432 MYLAN SPECIALITY LP Automatic injector with kickback attenuation
Sep, 2025

(2 years from now)

US7449012 MYLAN SPECIALITY LP Automatic injector
Sep, 2025

(2 years from now)

US8048035 MYLAN SPECIALITY LP Automatic injector with needle cover
Sep, 2025

(2 years from now)

Market Authorisation Date: 22 December, 1987

Treatment: NA

Dosage: INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS

More Information on Dosage
Strength Dosage Availability
0.15MG/DELIVERY INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS Prescription
0.3MG/DELIVERY INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS Prescription

5. Drug name - EPINEPHRINE

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10004700 BELCHER More potent and less toxic formulations of epinephrine and methods of medical use
Aug, 2034

(11 years from now)

US10039728 BELCHER More potent and less toxic formulations of epinephrine and methods of medical use
Aug, 2034

(11 years from now)

US9283197 BELCHER More potent and less toxic formulations of epinephrine and methods of medical use
Aug, 2034

(11 years from now)

Market Authorisation Date: 29 July, 2014

Treatment: Emergency treatment of allergic reactions (type 1), including anaphylaxis; A method of treating allergic reaction, anaphylaxis, anaphylactic shock, or combination thereof by an injection of at least one dosage of the injectable liquid pharmaceutical; Increasing mean arterial blood pressure in adult patients with hypotension associated with septic shock; Emergency treatment of allergic reactions (type i), including anaphylaxis; Induction and maintenance of mydriasis during intraocular surgery

Dosage: SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS; SOLUTION;INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS

More Information on Dosage
Strength Dosage Availability
10MG/10ML (1MG/ML) SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS Prescription
1MG/ML (1MG/ML) SOLUTION;INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS Prescription

6. Drug name - PRIMATENE MIST

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8367734 ARMSTRONG PHARMS Stable epinephrine suspension formulation with high inhalation delivery efficiency
Jan, 2026

(3 years from now)

Market Authorisation Date: 07 November, 2018

Treatment: NA

Dosage: AEROSOL, METERED;INHALATION

More Information on Dosage
Strength Dosage Availability
0.125MG/INH AEROSOL, METERED;INHALATION Over the counter

7. Drug name - SYMJEPI

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11141540 ADAMIS PHARMS CORP Syringe devices
Oct, 2036

(13 years from now)

Market Authorisation Date: 15 June, 2017

Treatment: A method for administering a therapeutic dose of epinephrine

Dosage: SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS

More Information on Dosage
Strength Dosage Availability
0.15MG/0.3ML (0.15MG/0.3ML) SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS Prescription
0.3MG/0.3ML (0.3MG/0.3ML) SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS Prescription

availability in other generic markets.

Click on the highlighted region to filter.